The Migraine Drugs Market Volume is experiencing unprecedented growth, with demand projected to reach USD 8.12 billion by 2035. This expansion is largely driven by innovative treatment options that are reshaping patient experiences and expectations. The market is expected to grow at a compound annual growth rate (CAGR) of 3.65% from 2024 to 2035. The surge in interest for effective migraine...